A new study published by Associate Professor Warren Rose reactivates two beta-lactam antibiotics against strains of MRSA in a lab simulation.
antibiotics
Long Delays Prescribing New Antibiotics Hinder Market for Needed Drugs
A survey of how 132 hospitals prescribed six new antibiotics from 2014 to 2018 found that the average time to prescribe any one of the new drugs was 398 days.
New Research Could Unlock Old Antibiotics to Treat MRSA
With a new R01 grant from the National Institutes of Health, Associate Professor Warren Rose is testing a MRSA subset that might not be as resistant to beta-lactams as previously thought.
$30 Million NIH Award will Help Tackle the Toughest Pathogens
Professor Tim Bugni and his colleagues receive $30 million grant from the NIH to take aim at the growing threat of multi-drug-resistant pathogens for which few — or no — treatment options exist.
Testing a New Antibiotic
Associate Professor Warren Rose’s new research collaboration with UW Health examines the effectiveness of a new antibiotic.
Gene-Editing Tool Now Being Used to Develop Better Antibiotics
Assistant Professor Jason Peters created a new technique, known as Mobile-CRISPRi, that allows scientists to screen for antibiotic function in a wide range of pathogenic bacteria.
New Assistant Professor Jason Peters Wins NIH Career Transition Award
The National Institutes of Health is helping Assistant Professor Jason Peters get to work developing CRISPR-based tools to uncover genetic functions crucial to the life and reproduction of pathogenic bacteria.
Searching the Sea, and Bacterial Battles, for New Antibiotics
The School’s Tim Bugni and Lingjun Li are using coculturing techniques to recreate aspects of real ecosystems to spur dormant and hidden antibiotic capacities into action.